UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Strategy Inc
MSTR
|
+$1.21B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$855M |
| 3 |
Microsoft
MSFT
|
+$810M |
| 4 |
Advanced Micro Devices
AMD
|
+$805M |
| 5 |
Boeing
BA
|
+$739M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$561M |
| 2 |
Amneal Pharmaceuticals
AMRX
|
+$169M |
| 3 |
Eli Lilly
LLY
|
+$161M |
| 4 |
Unity
U
|
+$158M |
| 5 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$127M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.49% |
| 2 | Financials | 9.06% |
| 3 | Consumer Discretionary | 7.01% |
| 4 | Healthcare | 6.25% |
| 5 | Industrials | 6.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EXK
5551
CALL
Endeavour Silver
EXK
$2.83B
| $732K | ﹤0.01% |
+200,000
| New | +$884K |
|
5552
Avalo Therapeutics
AVTX
$983M
| $732K | ﹤0.01% |
98,519
+92,385
| +1,506% | +$988K |
|
5553
Sana Biotechnology
SANA
$980M
| $732K | ﹤0.01% |
448,853
+144,115
| +47% | +$430K |
|
|
PGRE
5554
DELISTED
Paramount Group
PGRE
| $732K | ﹤0.01% |
148,101
+1,995
| +1% | +$9.86K |
|
|
PFN
5555
PIMCO Income Strategy Fund II
PFN
$703M
| $732K | ﹤0.01% |
98,198
-13,085
| -12% | -$98.4K |
|
5556
Ultrapar
UGP
$6.54B
| $731K | ﹤0.01% |
277,925
+256,600
| +1,203% | +$851K |
|
|
JPXN
5557
iShares JPX-Nikkei 400 ETF
JPXN
$140M
| $730K | ﹤0.01% |
10,310
+6,478
| +169% | +$475K |
|
|
GUG
5558
Guggenheim Active Allocation Fund
GUG
$511M
| $729K | ﹤0.01% |
49,047
+35,923
| +274% | +$564K |
|
5559
Taysha Gene Therapies
TSHA
$1.89B
| $729K | ﹤0.01% |
421,396
+329,395
| +358% | +$683K |
|
5560
Farmers National Banc Corp
FMNB
$930M
| $729K | ﹤0.01% |
51,257
+10,972
| +27% | +$163K |
|
5561
Horizon Bancorp
HBNC
$1.04B
| $729K | ﹤0.01% |
45,221
+9,673
| +27% | +$162K |
|
5562
PSQ Holdings
PSQH
$14.7M
| $728K | ﹤0.01% |
+10,691
| New | +$504K |
|
5563
Invesco Russell 2000 Dynamic Multifactor ETF
OMFS
$287M
| $728K | ﹤0.01% |
18,393
+2,248
| +14% | +$92.6K |
|
5564
MeiraGTx Holdings
MGTX
$1.21B
| $728K | ﹤0.01% |
119,484
+91,962
| +334% | +$539K |
|
5565
PetMed Express
PETS
$42.3M
| $727K | ﹤0.01% |
150,778
+84,559
| +128% | +$396K |
|
|
MOFG
5566
DELISTED
MidWestOne Financial Group
MOFG
| $726K | ﹤0.01% |
24,916
+16,240
| +187% | +$497K |
|
5567
Ultralife
ULBI
$106M
| $725K | ﹤0.01% |
97,369
+62,807
| +182% | +$516K |
|
5568
IBEX
IBEX
$499M
| $725K | ﹤0.01% |
33,746
+24,939
| +283% | +$490K |
|
5569
Midland States Bancorp
MSBI
$695M
| $725K | ﹤0.01% |
29,716
+14,662
| +97% | +$367K |
|
5570
Grupo Cibest SA
CIB
$21.1B
| $722K | ﹤0.01% |
22,928
+4,788
| +26% | +$154K |
|
5571
RE/MAX Holdings
RMAX
$242M
| $721K | ﹤0.01% |
67,609
+44,577
| +194% | +$535K |
|
5572
PUT
Realty Income
O
$59.1B
| $721K | ﹤0.01% |
13,500
+100
| +0.7% | +$5.82K |
|
5573
State Street SPDR Bloomberg 1-10 Year TIPS ETF
TIPX
$2.04B
| $719K | ﹤0.01% |
38,866
-2,161
| -5% | -$40.4K |
|
5574
PUT
Sprinklr
CXM
$1.61B
| $718K | ﹤0.01% |
85,000
| – | – |
|
5575
iShares MSCI Global Silver and Metals Miners ETF
SLVP
$944M
| $718K | ﹤0.01% |
62,203
-6,702
| -10% | -$89.3K |
|
Similar funds
UBS Group's Q4 2024 Portfolio in Review
As of Q4 2024, UBS Group held 10,816 positions worth $541B, up 18% from $459B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
UBS Group deployed $80.6B of net new capital in Q4 2024, opening 1,382 new positions and adding to 6,044 existing holdings. Its largest new stake was Primo Brands: 1,234,826 shares worth $38M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was UnitedHealth, an estimated $561M trimmed.
- UBS Group's largest Q4 2024 buy was Primo Brands: 1,234,826 shares worth $38M.
- UBS Group added most to Strategy Inc in Q4 2024, an estimated $1.21B increase.
- UBS Group's biggest Q4 2024 reduction was UnitedHealth, cutting an estimated $561M.
- UBS Group fully exited CATALENT, INC. in Q4 2024, selling an estimated $86M.
- UBS Group's ten largest holdings make up 16% of its $541B portfolio in Q4 2024.
- UBS Group opened 1,382 new positions and closed 943 in Q4 2024.
- UBS Group's portfolio value rose 18% quarter-over-quarter to $541B.
Based on UBS Group's 13F filing for Q4 2024, filed 14 Feb 2025.